These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35713775)

  • 1. Moving the Dial Toward Equity in Parkinson's Disease Clinical Research: a Review of Current Literature and Future Directions in Diversifying PD Clinical Trial Participation.
    Adrissi J; Fleisher J
    Curr Neurol Neurosci Rep; 2022 Aug; 22(8):475-483. PubMed ID: 35713775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overcoming Barriers to Parkinson Disease Trial Participation: Increasing Diversity and Novel Designs for Recruitment and Retention.
    Vaswani PA; Tropea TF; Dahodwala N
    Neurotherapeutics; 2020 Oct; 17(4):1724-1735. PubMed ID: 33150545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does Ethnicity Influence Recruitment into Clinical Trials of Parkinson's Disease?
    Lau YH; Podlewska A; Ocloo J; Gupta A; Gonde C; Bloem BR; Chaudhuri KR
    J Parkinsons Dis; 2022; 12(3):975-981. PubMed ID: 35068418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Designing the Fostering Inclusivity in Research Engagement for Underrepresented Populations in Parkinson's Disease study.
    Sanchez AV; Ison JM; Hemley H; Willis A; Siddiqi B; Macklin EA; Ulysse C; Reynolds M; Schwarzschild MA; Jackson JD
    Contemp Clin Trials; 2022 Apr; 115():106713. PubMed ID: 35202842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community engagement and clinical trial diversity: Navigating barriers and co-designing solutions-A report from the "Health Equity through Diversity" seminar series.
    Reopell L; Nolan TS; Gray DM; Williams A; Brewer LC; Bryant AL; Wilson G; Williams E; Jones C; McKoy A; Grever J; Soliman A; Baez J; Nawaz S; Walker DM; Metlock F; Zappe L; Gregory J; Joseph JJ
    PLoS One; 2023; 18(2):e0281940. PubMed ID: 36795792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Call to Action: Promoting Diversity, Equity, and Inclusion in Parkinson's Research and Care.
    Siddiqi B; Koemeter-Cox A
    J Parkinsons Dis; 2021; 11(3):905-908. PubMed ID: 33843698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minority enrollment in Parkinson's disease clinical trials.
    Schneider MG; Swearingen CJ; Shulman LM; Ye J; Baumgarten M; Tilley BC
    Parkinsonism Relat Disord; 2009 May; 15(4):258-62. PubMed ID: 18693062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized recruitment intervention trial in Parkinson's disease to increase participant diversity: early stopping for lack of efficacy.
    Tilley BC; Mainous AG; Elm JJ; Pickelsimer E; Soderstrom LH; Ford ME; Diaz VA; Siminoff LA; Burau K; Smith DW
    Clin Trials; 2012 Apr; 9(2):188-97. PubMed ID: 22496398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minority Enrollment in Parkinson's Disease Clinical Trials: Meta-Analysis and Systematic Review of Studies Evaluating Treatment of Neuropsychiatric Symptoms.
    Di Luca DG; Sambursky JA; Margolesky J; Cordeiro JG; Diaz A; Shpiner DS; Moore HP; Singer C; Luca C
    J Parkinsons Dis; 2020; 10(4):1709-1716. PubMed ID: 32894250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health Disparities in Recruitment and Enrollment in Research.
    Hasson Charles RM; Sosa E; Patel M; Erhunmwunsee L
    Thorac Surg Clin; 2022 Feb; 32(1):75-82. PubMed ID: 34801198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innovative Recruitment Strategies to Increase Diversity of Participation in Parkinson's Disease Research: The Fox Insight Cohort Experience.
    Dobkin RD; Amondikar N; Kopil C; Caspell-Garcia C; Brown E; Chahine LM; Marras C; Dahodwala N; Mantri S; Standaert DG; Dean M; Shoulson I; Marek K; Katz A; Korell M; Riley L; Tanner CM;
    J Parkinsons Dis; 2020; 10(2):665-675. PubMed ID: 32250321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Equitable Representation of Latinos in Clinical Research Is Needed to Achieve Health Equity in Cancer Care.
    Ramirez AG; Chalela P
    JCO Oncol Pract; 2022 May; 18(5):e797-e804. PubMed ID: 35544655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enrollment of Participants From Marginalized Racial and Ethnic Groups: A Comparative Assessment of the STEADY-PD III and SURE-PD3 Trials.
    Di Luca DG; Macklin EA; Hodgeman K; Lopez G; Pothier L; Callahan KF; Lowell J; Chan J; Videnovic A; Lungu C; Lang AE; Litvan I; Schwarzschild MA; Simuni T
    Neurol Clin Pract; 2023 Feb; 13(1):e200113. PubMed ID: 36865634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applying a Conceptual Framework to Maximize the Participation of Diverse Populations in Cancer Clinical Trials.
    Napoles A; Cook E; Ginossar T; Knight KD; Ford ME
    Adv Cancer Res; 2017; 133():77-94. PubMed ID: 28052822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing Racial and Ethnic Diversity in Cancer Clinical Trials: An American Society of Clinical Oncology and Association of Community Cancer Centers Joint Research Statement.
    Oyer RA; Hurley P; Boehmer L; Bruinooge SS; Levit K; Barrett N; Benson A; Bernick LA; Byatt L; Charlot M; Crews J; DeLeon K; Fashoyin-Aje L; Garrett-Mayer E; Gralow JR; Green S; Guerra CE; Hamroun L; Hardy CM; Hempstead B; Jeames S; Mann M; Matin K; McCaskill-Stevens W; Merrill J; Nowakowski GS; Patel MI; Pressman A; Ramirez AG; Segura J; Segarra-Vasquez B; Hanley Williams J; Williams JE; Winkfield KM; Yang ES; Zwicker V; Pierce LJ
    J Clin Oncol; 2022 Jul; 40(19):2163-2171. PubMed ID: 35588469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recruitment strategies and patient selection in clinical trials for Parkinson's disease: Going viral and keeping science and ethics at the highest standards.
    Picillo M; Kou N; Barone P; Fasano A
    Parkinsonism Relat Disord; 2015 Sep; 21(9):1041-8. PubMed ID: 26228079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial and Social Disparities in Health and Health Care Delivery among Patients with Parkinson's Disease and Related Disorders in a Multiracial Clinical Setting.
    Nwabuobi L; Agee J; Gilbert R
    J Cross Cult Gerontol; 2021 Sep; 36(3):253-263. PubMed ID: 34398367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dialogues on diversifying clinical trials: successful strategies for engaging women and minorities in clinical trials.
    Coakley M; Fadiran EO; Parrish LJ; Griffith RA; Weiss E; Carter C
    J Womens Health (Larchmt); 2012 Jul; 21(7):713-6. PubMed ID: 22747427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recruitment of racial and ethnic minorities to clinical trials conducted within specialty clinics: an intervention mapping approach.
    Amorrortu RP; Arevalo M; Vernon SW; Mainous AG; Diaz V; McKee MD; Ford ME; Tilley BC
    Trials; 2018 Feb; 19(1):115. PubMed ID: 29454389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.